<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Holbrook Lausen | Activity</title>
	<link>https://www.catswannabecats.com/members/chardflesh2/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/chardflesh2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Holbrook Lausen.</description>
	<lastBuildDate>Tue, 30 Jun 2026 07:59:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b99436c74f52a3b201851bc70193e1ee</guid>
				<title>Holbrook Lausen posted an update: Such screen-and-stratify pipelines should consider tumor [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23638/</link>
				<pubDate>Sun, 08 Jun 2025 09:58:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>Such screen-and-stratify pipelines should consider tumor heterogeneity as well as the role of immune effectors in the tumor microenvironment and may lead to biomarker discovery advancing the oncology field toward personalized options with improved translatability to clinical settings. This opinion-based review provides a critical overview of&hellip;<span class="activity-read-more" id="activity-read-more-23638"><a href="https://www.catswannabecats.com/activity/p/23638/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6c610cb1c2e29bb4f657722267113a2c</guid>
				<title>Holbrook Lausen posted an update: Loss-of-function experiments were performed to determine the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12407/</link>
				<pubDate>Sun, 01 Jun 2025 09:27:42 -0400</pubDate>

									<content:encoded><![CDATA[<p>Loss-of-function experiments were performed to determine the biological functions of SLC16A1-AS in OSCC cells. Silencing SLC16A1-AS1 significantly reduced the cell proliferation rate and colony-forming ability in both CAL27 and SCC25 cell lines. Flow cytometry and western blot analysis revealed that SLC16A1-AS1 silencing induced G0/G1 cell cycle&hellip;<span class="activity-read-more" id="activity-read-more-12407"><a href="https://www.catswannabecats.com/activity/p/12407/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d797dcc8f4fd98fe8d78004b527a8871</guid>
				<title>Holbrook Lausen posted an update: Loss-of-function experiments were performed to determine the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12355/</link>
				<pubDate>Sun, 01 Jun 2025 09:18:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>Loss-of-function experiments were performed to determine the biological functions of SLC16A1-AS in OSCC cells. Silencing SLC16A1-AS1 significantly reduced the cell proliferation rate and colony-forming ability in both CAL27 and SCC25 cell lines. Flow cytometry and western blot analysis revealed that SLC16A1-AS1 silencing induced G0/G1 cell cycle&hellip;<span class="activity-read-more" id="activity-read-more-12355"><a href="https://www.catswannabecats.com/activity/p/12355/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2b22123cf3c8e57ef89b629e880b6176</guid>
				<title>Holbrook Lausen posted an update: The relationship between antiphospholipid antibodies (aPL) [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/6321/</link>
				<pubDate>Sat, 31 May 2025 16:15:32 -0400</pubDate>

									<content:encoded><![CDATA[<p>The relationship between antiphospholipid antibodies (aPL) and autoimmune haemolytic anaemia (AIHA) has never been systematically addressed. The aim of this study is to assess the link between aPL and AIHA in adult systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). This study performed an EMBASE/PubMed search from inception to&hellip;<span class="activity-read-more" id="activity-read-more-6321"><a href="https://www.catswannabecats.com/activity/p/6321/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a9f6d9b47e64bf80c2116190d868afd8</guid>
				<title>Holbrook Lausen became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/6220/</link>
				<pubDate>Sat, 31 May 2025 16:03:45 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>